RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-01 ,pp. : 45-50

Karger

Access to resources Recommend Favorite

HGF-MET in Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 228-233

Bentham Science Publishers

Access to resources Recommend Favorite

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2947-2958

John Wiley & Sons Inc

Access to resources Recommend Favorite

EGFR-Blockade mit Gefitinib. Erfolge beim NSCLC

By  

Oncology Research and Treatment, Vol. 27, Iss. 3, 2004-07 ,pp. : 322-323

Karger

Access to resources Recommend Favorite

EGFR-TKI Treatment and Surgical Resection for Oligometastatic NSCLC?

By  

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 627-628

Karger

Access to resources Recommend Favorite